Dt&Cro

Dt&Cro runs clinical and preclinical trials on behalf of pharmaceutical, medical-device, health-supplement, and cosmetics companies that need independent scientific testing before they can bring a new product to market.

As a full-service contract research organisation (CRO), it handles every stage of the testing pipeline, from early animal-based safety and efficacy studies conducted under internationally recognised good-laboratory-practice standards, through all phases of human clinical trials under good-clinical-practice standards, to regulatory consulting for approvals including the US FDA. Its analytical centre also provides pharmacokinetic and toxicokinetic data used in generic-drug approvals and new-drug development. The company is listed on KOSDAQ, South Korea's technology and small-cap exchange.